Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.4K
Overview
44.4K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

771
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
771
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

483
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
483
Leaky Scanning02:28

Leaky Scanning

5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

252
The pathophysiology of pneumonia involves the following steps:
252
Development of Immunocompetence01:22

Development of Immunocompetence

301
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
301

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Broad neutralization of influenza B hemagglutinin antibodies via receptor mimicry and glycan engagement.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Altering the carbohydrate-binding specificity of the legume lectin FRIL through structure-guided engineering.

Nature communications·2026
Same author

Poly-β-D-(1,6)-N-acetyl-glucosamine (PNAG) glycan vaccines with broad spectrum neutralizing activities.

Nature communications·2025
Same author

Chemical and Enzymatic Synthesis of DisialylGb5 and Other Sialosides for Glycan Array Assembly and Evaluation of Siglec-Mediated Immune Checkpoint Inhibition.

Molecules (Basel, Switzerland)·2025
Same author

Synthesis of PSI Oligosaccharide for the Development of Total Synthetic Vaccine against <i>Clostridium difficile</i>.

The Journal of organic chemistry·2025
Same author

Expression of Human β3GalT5-1 in Insect Cells as Active Glycoforms for the Efficient Synthesis of Cancer-Associated Globo-Series Glycans.

Journal of the American Chemical Society·2025

Related Experiment Video

Updated: Jun 22, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.4K

An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus Infection.

Shiou-Chih Hsu1, Kun-Hsien Lin1, Yung-Chieh Tseng1

  • 1Genomics Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 115201, Taiwan.

Vaccines
|June 27, 2024
PubMed
Summary

Adjuvants can unexpectedly cause disease in flu vaccines, even with high antibody levels. Researchers emphasize developing precise adjuvants for safe, effective vaccination without harmful side effects.

Keywords:
NKT cellsadjuvantinfluenza viruspathogenesisprecision medicinevaccine

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.9K
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.6K

Related Experiment Videos

Last Updated: Jun 22, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.4K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.9K
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.6K

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • Adjuvants are critical for vaccine efficacy, but their impact on immune responses can be complex.
  • Incomplete Freund's adjuvant (IFA) induced pathogenesis in H1N1-challenged mice, despite high antibody titers.
  • Aluminum hydroxide (AH) adjuvants, in contrast, showed no pathogenic signs with glycolipids.

Purpose of the Study:

  • To investigate the differential effects of adjuvants on immune responses and vaccine-induced pathogenesis.
  • To evaluate the role of glycolipids and their analogues in modulating adjuvant activity.
  • To establish the protective potential of aluminum hydroxide adjuvants against influenza A virus.

Main Methods:

  • Intranasal challenge of vaccinated mice with A/California/07/2009 (H1N1) virus.
  • Assessment of pathogenic signs, antibody titers, and immune response modulation.
  • Comparative analysis of different adjuvant formulations, including IFA, AH, glycolipids (α-galactosyl ceramide), and synthetic analogues (C34).

Main Results:

  • IFA induced pathogenesis, while AH alone provided complete protection against lethal influenza A challenge.
  • α-galactosyl ceramide enhanced anti-influenza A antibody responses when combined with adjuvants.
  • The synthetic analogue C34 antagonized the stimulatory effect of AH on specific antibody responses.

Conclusions:

  • Adjuvants can significantly alter immune responses, leading to either enhanced immunity or adverse pathogenic consequences.
  • The choice of adjuvant is crucial for achieving safe and effective vaccination.
  • Development of precision adjuvants is paramount for innocuous vaccination strategies that generate protective immunity without aberrant responses.